(Q64929653)

English

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.

scientific article published on 14 June 2019

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer. (English)

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Seppo Ylä-Herttuala

5

object named as

Seppo Ylä-Herttuala

1 reference

Europe PubMed Central

1 July 2019

Veli-Matti Kosma

6

object named as

Veli-Matti Kosma

1 reference

Europe PubMed Central

1 July 2019

Kirsi Hämäläinen

3

object named as

Kirsi Hämäläinen

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

2

object named as

Maarit Anttila

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Leea Keski-Nisula

7

object named as

Leea Keski-Nisula

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

1

object named as

Minna Sopo

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

author name string

Annukka Kivelä

4

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Hanna Sallinen

8

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

language of work or name

0 references

publication date

14 June 2019

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

19

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

1

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

584

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent association of angiogenesis index with outcome in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cancer biomarker problem

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporation of bevacizumab in the primary treatment of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 3 trial of bevacizumab in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis Markers in Gynecological Tumors and Patents for Anti-Angiogenic Approach: Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why some tumours trigger neovascularisation and others don't: the story thus far.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-angiogenic agents in ovarian cancer: past, present, and future.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/31200683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12885-019-5757-3

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6570919

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64929653&oldid=2116786572"